121 related articles for article (PubMed ID: 10217600)
1. Induction of mucosal immunity with a replication-defective adenoviral recombinant.
Xiang Z; Ertl HC
Vaccine; 1999 Apr; 17(15-16):2003-8. PubMed ID: 10217600
[TBL] [Abstract][Full Text] [Related]
2. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.
Xiang ZQ; Pasquini S; Ertl HC
J Immunol; 1999 Jun; 162(11):6716-23. PubMed ID: 10352290
[TBL] [Abstract][Full Text] [Related]
3. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
6. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
[TBL] [Abstract][Full Text] [Related]
7. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
[TBL] [Abstract][Full Text] [Related]
8. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
[TBL] [Abstract][Full Text] [Related]
9. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
[TBL] [Abstract][Full Text] [Related]
10. Immune response to neonatal genetic immunization.
Wang Y; Xiang Z; Pasquini S; Ertl HC
Virology; 1997 Feb; 228(2):278-84. PubMed ID: 9123835
[TBL] [Abstract][Full Text] [Related]
11. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
12. A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice.
Li Z; Wang J; Yuan D; Wang S; Sun J; Yi B; Hou Q; Mao Y; Liu W
Virus Genes; 2015 Jun; 50(3):434-41. PubMed ID: 25764477
[TBL] [Abstract][Full Text] [Related]
13. Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep.
DeMartini JC; Bickle HM; Brodie SJ; He BX; Esposito JJ
Arch Virol; 1993; 133(1-2):211-22. PubMed ID: 8240013
[TBL] [Abstract][Full Text] [Related]
14. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
[TBL] [Abstract][Full Text] [Related]
16. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
[TBL] [Abstract][Full Text] [Related]
17. Plasmid vectors as anti-viral vaccines.
Ertl HC; Verma P; He Z; Xiang ZQ
Ann N Y Acad Sci; 1995 Nov; 772():77-87. PubMed ID: 8546415
[No Abstract] [Full Text] [Related]
18. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.
Wang Y; Xiang Z; Pasquini S; Ertl HC
J Virol; 1998 Mar; 72(3):1790-6. PubMed ID: 9499029
[TBL] [Abstract][Full Text] [Related]
19. T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells.
Xiang ZQ; Gao GP; Li Y; Wilson JM; Ertl HC
Virology; 2003 Jan; 305(2):397-405. PubMed ID: 12573585
[TBL] [Abstract][Full Text] [Related]
20. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
